How is the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the chronic obstructive pulmonary disease (copd) treatment market size evolved in recent years?
The market size for the treatment of chronic obstructive pulmonary disease (COPD) has experienced significant growth in recent years. Its size is projected to increase from $20.84 billion in 2024 to $21.94 billion in 2025, with a compound annual growth rate (CAGR) of 5.3%. Factors that have contributed to this growth in the historical period include the widespread incidence of smoking and tobacco use, progress in inhalation therapies, initiatives to raise awareness and ensure early diagnosis, government efforts to improve respiratory health, and advances in pulmonology research.
What are the predictions for the chronic obstructive pulmonary disease (copd) treatment market size in the coming years?
The market size for the treatment of chronic obstructive pulmonary disease (COPD) is anticipated to witness significant growth in the upcoming years, expanding to “$27.74 billion by 2029 with a compound annual growth rate (CAGR) of 6.0%. The growth in this time frame is due to factors such as personalized medicine and biomarker research, specialized therapies, considerations about air quality and the environment, worldwide smoking cessation efforts, as well as drug development collaborations. Upcoming trends for this duration are COPD management through digital health solutions, COPD biologic therapies, the rise of personalized medicine, combination therapies and inhalers, early detection and intervention, and the implication of pulmonary rehabilitation programs.
Get your chronic obstructive pulmonary disease (copd) treatment market report here!
What key factors are fueling the growth of the chronic obstructive pulmonary disease (copd) treatment market?
The escalating prevalence of lung-related ailments is anticipated to fuel the expansion of the chronic obstructive pulmonary disease (COPD) treatment market. Lung disease is an ailment that interferes with the normal operation of the lungs. The most widespread lung diseases are asthma, COPD, and lung cancer. Treatment for chronic obstructive pulmonary disease (COPD) is primarily utilized for managing lung disease, slowing its development, managing symptoms, and preventing damage to the lungs through the use of inhalers and medications. For instance, in September 2022, the global initiative for Chronic obstructive lung disease (GOLD), a US-based non-profit organization, reported that 3.2 million people die from COPD annually, which impacts an estimated 200 million people. Furthermore, asthma had a global impact on 262 million people in 2022. These statistics are foreseen to escalate in the future. Additionally, in 2023, the LUNGevity Foundation, another US-based non-profit organization, predicted that 127,000 Americans will succumb to lung cancer every year. As such, the growing frequency of lung disease is propelling the chronic obstructive pulmonary disease (COPD) treatment market’s growth.
How is the global chronic obstructive pulmonary disease (copd) treatment market divided into key segments?
The chronic obstructive pulmonary disease (COPD) treatment market covered in this report is segmented –
1) By Drug Class: Combination Therapy, Bronchodilators, Corticosteroids, Phosphodiesterase Type 4 Inhibitor, Mucokinetics, Other Drug Classes
2) By Type: Chronic Bronchitis, Emphysema
3) By End-User: Hospitals, Clinics, Homecare Settings
Subsegments:
1) By Combination Therapy: Long-Acting Beta-Agonists (LABA) + Inhaled Corticosteroids (ICS), Long-Acting Muscarinic Antagonists (LAMA) + LABA, Triple Therapy (LAMA + LABA + ICS)
2) By Bronchodilators: Short-Acting Beta-Agonists (SABA), Long-Acting Beta-Agonists (LABA), Long-Acting Muscarinic Antagonists (LAMA)
3) By Corticosteroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Injectable Corticosteroids
4) By Phosphodiesterase Type 4 Inhibitor: Roflumilast, Other PDE4 Inhibitors
5) By Mucokinetics: Expectorants, Mucolytics
6) By Other Drug Classes: Antibiotics, Antivirals, Antifungal Agents
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10054&type=smp
Who are the key firms paving the way for growth in the chronic obstructive pulmonary disease (copd) treatment market?
Major companies operating in the chronic obstructive pulmonary disease (COPD) treatment market include Almirall S.A., AstraZeneca plc, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Novartis AG, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Abbott Laboratories, Chiesi Farmaceutici S.p.A, Mylan N.V., Orion Corporation, Sunovion Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., Circassia Group PLC, Kyowa Kirin Co. Ltd., Sanofi S.A, Theravance Biopharma Inc., Verona Pharmaceuticals plc, Alcon Laboratories Inc., Amgen Inc., Apotex Inc., Aurobindo Pharma Limited, Biocon Limited, Biogen Inc., Bristol-Myers Squibb Company, Cipla Limited, Eli Lilly and Company, Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals plc, Lupin Limited, Meda AB, Mundipharma International Limited, Pfizer Inc.
Which trends are expected to transform the chronic obstructive pulmonary disease (copd) treatment market?
Boosting product innovation serves as an increasingly dominant trend in the chronic obstructive pulmonary disease (COPD) treatment market. Esteemed corporations involved in this market prioritize the development of pioneering products as a strategy for maintaining their standing. For instance, in April 2022, GlaxoSmithKline plc (GSK), a pharmaceutical and biotech company rooted in the United Kingdom, introduced Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol), making it the first single-inhaler triple therapy (SITT) for Indian COPD patients. Trelegy Ellipta is utilized for ongoing treatment and prevention of COPD signs and symptoms in individuals aged 18 and above. It operates similarly to natural corticosteroid hormones by binding to specific receptors on certain immune cells, reducing their activity. It also aids by decreasing airway swelling within the lungs, thereby simplifying the breathing process.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10054
What regions are contributing significantly to the growth of the chronic obstructive pulmonary disease (copd) treatment market?
North America was the largest region in the chronic obstructive pulmonary disease (COPD) treatment market in 2024.Asia-Pacific is expected to be the global chronic obstructive pulmonary disease (COPD) treatment market report during the fastest-growing region in the forecast period. The regions covered in the chronic obstructive pulmonary disease (COPD) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Endoscopy Devices And Equipment Global Market Report 2024
Gastrointestinal Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report
Dialysis Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
